- cafead Aug 22, 2024 at 11:12: AM
via Everest Medicines has commenced an investigator-initiated clinical trial (IIT) of its personalised mRNA cancer vaccine, EVM16.
The trial, named EVM16CX01, is being conducted at the Peking University Cancer Hospital and Fudan University’s Cancer Hospital in China.
article source
The trial, named EVM16CX01, is being conducted at the Peking University Cancer Hospital and Fudan University’s Cancer Hospital in China.
article source